Clinical outcome of HIV-infected patients with sustained virologic response to antiretroviral therapy: long-term follow-up of a multicenter cohort (Q33267347)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Clinical outcome of HIV-infected patients with sustained virologic response to antiretroviral therapy: long-term follow-up of a multicenter cohort	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

24 July 2017

Clinical outcome of HIV-infected patients with sustained virologic response to antiretroviral therapy: long-term follow-up of a multicenter cohort (English)

1 reference

Europe PubMed Central

24 July 2017

multicenter clinical trial

0 references

0 references

anti-retroviral agent

0 references

object named as

Francesc Vidal

9

0 references

0 references

author name string

Félix Gutierrez

1

1 reference

Europe PubMed Central

24 July 2017

Sergio Padilla

2

1 reference

Europe PubMed Central

24 July 2017

Mar Masiá

3

1 reference

Europe PubMed Central

24 July 2017

José A Iribarren

4

1 reference

Europe PubMed Central

24 July 2017

Santiago Moreno

5

1 reference

Europe PubMed Central

24 July 2017

Pompeyo Viciana

6

1 reference

Europe PubMed Central

24 July 2017

Leopoldo Muñoz

7

1 reference

Europe PubMed Central

24 July 2017

José L Gómez Sirvent

8

1 reference

Europe PubMed Central

24 July 2017

José López-Aldeguer

10

1 reference

Europe PubMed Central

24 July 2017

José R Blanco

11

1 reference

Europe PubMed Central

24 July 2017

Manuel Leal

12

1 reference

Europe PubMed Central

24 July 2017

María Angeles Rodríguez-Arenas

13

1 reference

Europe PubMed Central

24 July 2017

Santiago Perez Hoyos

14

1 reference

Europe PubMed Central

24 July 2017

CoRIS-MD

15

1 reference

Europe PubMed Central

24 July 2017

language of work or name

0 references

publication date

20 December 2006

1 reference

Europe PubMed Central

24 July 2017

1 reference

Europe PubMed Central

24 July 2017

1

1 reference

Europe PubMed Central

24 July 2017

e89

1 reference

Europe PubMed Central

24 July 2017

copyright license

Creative Commons Attribution 4.0 International

20 December 2006

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Immunologic response to antiretroviral therapy in hepatitis C virus-coinfected adults in a population-based HIV/AIDS treatment program

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1762396

21 June 2018

Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1762396

21 June 2018

Response to Highly Active Antiretroviral Therapy at 6 Months and Long-Term Disease Progression in HIV-1 Infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1762396

21 June 2018

Decline in the AIDS and death rates in the EuroSIDA study: an observational study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1762396

21 June 2018

Effectiveness of highly active antiretroviral therapy in Spanish cohorts of HIV seroconverters: differences by transmission category

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1762396

21 June 2018

Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1762396

21 June 2018

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1762396

21 June 2018

Perspective: validating surrogate markers--are we being naive?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1762396

21 June 2018

Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1762396

21 June 2018

Prognosis in HIV-1 infection predicted by the quantity of virus in plasma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1762396

21 June 2018

HIV-1 RNA, CD4 cell count and the risk of progression to AIDS and death during treatment with HIV-1 reverse transcriptase inhibitors

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0000089

21 January 2018

Predictors of virologic and clinical outcomes in HIV-1-infected patients receiving concurrent treatment with indinavir, zidovudine, and lamivudine. AIDS Clinical Trials Group Protocol 320.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0000089

21 January 2018

Delay in the initiation of HAART, poorer virological response, and higher mortality among HIV-infected injecting drug users in Spain.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0000089

21 January 2018

Discordant immunologic and virologic responses to highly active antiretroviral therapy are associated with increased mortality and poor adherence to therapy

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0000089

21 January 2018

Discordant immunological and virological responses to antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0000089

21 January 2018

Prognostic factors of combined viral load and CD4+ cell count responses under triple antiretroviral therapy, Aquitaine cohort, 1996-1998.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0000089

21 January 2018

Long-term clinical outcome of human immunodeficiency virus-infected patients with discordant immunologic and virologic responses to a protease inhibitor-containing regimen

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0000089

21 January 2018

Determinants of clinical progression in antiretroviral-naive HIV-infected patients starting highly active antiretroviral therapy. Aquitaine Cohort, France, 1996-2002.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0000089

21 January 2018

Changing spectrum of mortality due to human immunodeficiency virus: analysis of 260 deaths during 1995--1999.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0000089

21 January 2018

Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0000089

21 January 2018

Effect of Medication Adherence on Survival of HIV-Infected Adults Who Start Highly Active Antiretroviral Therapy When the CD4+ Cell Count Is 0.200 to 0.350 × 109 cells/L

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0000089

21 January 2018

Impact of antiretroviral combination therapies on AIDS surveillance reports in Switzerland

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0000089

21 January 2018

Immunologic and clinical responses to highly active antiretroviral therapy over 50 years of age. Results from the French Hospital Database on HIV

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0000089

21 January 2018

Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0000089

21 January 2018

Risk of AIDS and death at given HIV-RNA and CD4 cell count, in relation to specific antiretroviral drugs in the regimen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1762396

31 October 2018

Changes in the cause of death among HIV positive subjects across Europe: results from the EuroSIDA study

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0000089

21 January 2018

The clinical profile of end-stage AIDS in the era of highly active antiretroviral therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/17183720

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Changes in the spectrum of morbidity and mortality in hospital admissions of HIV infected patients during the HAART era]

1 reference

https://pubmed.ncbi.nlm.nih.gov/17183720

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Functional Genomic Analysis of the Response of HIV‐1–Infected Lymphatic Tissue to Antiretroviral Therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/17183720

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Disease progression in patients with virological suppression in response to HAART is associated with the degree of immunological response

1 reference

https://pubmed.ncbi.nlm.nih.gov/17183720

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mortality for Liver Disease in Patients With HIV Infection: A Cohort Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17183720

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical Outcome of Patients with HIV-1 Infection according to Immunologic and Virologic Response after 6 Months of Highly Active Antiretroviral Therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/17183720

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modeling changes in CD4-positive T-lymphocyte counts after the start of highly active antiretroviral therapy and the relation with risk of opportunistic infections: the Aquitaine Cohort, 1996-1997

1 reference

https://pubmed.ncbi.nlm.nih.gov/17183720

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Overview of the effectiveness of triple combination therapy in antiretroviral-naive HIV-1 infected adults

1 reference

https://pubmed.ncbi.nlm.nih.gov/17183720

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0000089

1 reference

Europe PubMed Central

24 July 2017

2006PLoSO...1...89G

0 references

1 reference

Europe PubMed Central

24 July 2017

1 reference

Europe PubMed Central

24 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33267347&oldid=1975261463"